fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
News|Videos|August 21, 2017
What Should Pharmacists Advise Diabetes Patients About Lifestyle Modifications?
In this clip, Brooke Hudspeth, PharmD, CDE, of the Kroger Co., explains how pharmacists can play a role in reinforcing the importance of lifestyle modifications for the prevention and management of type 2 diabetes.
Advertisement
In this clip, Brooke Hudspeth, PharmD, CDE, of the Kroger Co., explains how pharmacists can play a role in reinforcing the importance of lifestyle modifications for the prevention and management of type 2 diabetes.
Advertisement
Related to this article
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1C reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
Novo Nordisk's top-line phase 3 data show 12.4% weight loss with CagriSema 1.0 mg/1.0 mg in type 2 diabetes and 21.0% in adults with overweight or obesity.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
2
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
Increasing Daily Steps Matches Aerobic Training for Asthma Control in Randomized Trial
5